Detalhe da pesquisa
1.
A nationwide phase II study of delayed local treatment for children with high-risk neuroblastoma: The Japan Children's Cancer Group Neuroblastoma Committee Trial JN-H-11.
Pediatr Blood Cancer
; 71(6): e30976, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38577760
2.
Asymmetric Pericentrosomal CD133 Endosomes Induce the Unequal Autophagic Activity During Cytokinesis in CD133-Positive Human Neuroblastoma Cells.
Stem Cells
; 40(4): 371-384, 2022 04 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35284915
3.
Outcome of children with relapsed high-risk neuroblastoma in Japan and analysis of the role of allogeneic hematopoietic stem cell transplantation.
Jpn J Clin Oncol
; 52(5): 486-492, 2022 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35137156
4.
Collagen XI Alpha 1 (COL11A1) Expression in the Tumor Microenvironment Drives Neuroblastoma Dissemination.
Pediatr Dev Pathol
; 25(2): 91-98, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34460335
5.
Medical guidelines for Li-Fraumeni syndrome 2019, version 1.1.
Int J Clin Oncol
; 26(12): 2161-2178, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34633580
6.
De novo evolved gene product NCYM in the pathogenesis and clinical outcome of human neuroblastomas and other cancers.
Jpn J Clin Oncol
; 50(8): 839-846, 2020 Aug 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32577751
7.
Correction to: Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG).
Int J Clin Oncol
; 25(9): 1744-1745, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32749556
8.
TAp63 represses transcription of MYCN/NCYM gene and its high levels of expression are associated with favorable outcome in neuroblastoma.
Biochem Biophys Res Commun
; 518(2): 311-318, 2019 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31427086
9.
Tumor suppressor KIF1Bß regulates mitochondrial apoptosis in collaboration with YME1L1.
Mol Carcinog
; 58(7): 1134-1144, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30859632
10.
PPP3CB contributes to poor prognosis through activating nuclear factor of activated T-cells signaling in neuroblastoma.
Mol Carcinog
; 58(3): 426-435, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30457174
11.
Programmed expression of pro-apoptotic BMCC1 during apoptosis, triggered by DNA damage in neuroblastoma cells.
BMC Cancer
; 19(1): 542, 2019 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31170959
12.
Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
Pediatr Blood Cancer
; 66(8): e27819, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31115156
13.
Results of a prospective clinical trial JN-L-10 using image-defined risk factors to inform surgical decisions for children with low-risk neuroblastoma disease: A report from the Japan Children's Cancer Group Neuroblastoma Committee.
Pediatr Blood Cancer
; 66(11): e27914, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31342649
14.
Co-Inhibition of the DNA Damage Response and CHK1 Enhances Apoptosis of Neuroblastoma Cells.
Int J Mol Sci
; 20(15)2019 Jul 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31362335
15.
Neuroblastoma.
Jpn J Clin Oncol
; 48(3): 214-241, 2018 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29378002
16.
Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG).
Int J Clin Oncol
; 23(5): 965-973, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29700636
17.
Correction to: Medical guidelines for Li-Fraumeni syndrome 2019, version 1.1.
Int J Clin Oncol
; 27(1): 262-263, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34859328
18.
NCYM, a Cis-antisense gene of MYCN, encodes a de novo evolved protein that inhibits GSK3ß resulting in the stabilization of MYCN in human neuroblastomas.
PLoS Genet
; 10(1): e1003996, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24391509
19.
Unfavorable neuroblastoma prognostic factor NLRR2 inhibits cell differentiation by transcriptional induction through JNK pathway.
Cancer Sci
; 107(9): 1223-32, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27357360
20.
Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group project.
Cancer
; 122(6): 935-45, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26709890